These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20228994)

  • 41. Lung function in Lolland-Falster Health Study (LOFUS).
    Jacobsen KK; Jepsen R; Bodtger U; Rasmussen K; St-Martin G
    Clin Respir J; 2022 Oct; 16(10):657-668. PubMed ID: 36056580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of the FEV1/FEV6 ratio compared to the FEV1/FVC ratio for the diagnosis of airway obstruction in subjects aged 40 years or over.
    Rosa FW; Perez-Padilla R; Camelier A; Nascimento OA; Menezes AM; Jardim JR;
    Braz J Med Biol Res; 2007 Dec; 40(12):1615-21. PubMed ID: 17906778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COPD 'diagnosis' based on spirometric reference equations.
    Olofson J; Bake B; Tengelin MN; Houltz B
    Clin Respir J; 2008 Oct; 2(4):214-9. PubMed ID: 20298337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the lower confidence limit to the fixed-percentage method for assessing airway obstruction in routine clinical practice.
    Aggarwal AN; Gupta D; Agarwal R; Jindal SK
    Respir Care; 2011 Nov; 56(11):1778-84. PubMed ID: 21605485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the Global Lung Function Initiative 2012 reference values for spirometry in an Iranian population.
    Sahebi L; Rahimi B; Shariat M; Mousavy SH
    Sci Rep; 2022 Jul; 12(1):12784. PubMed ID: 35896706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is an FEV
    König P; Ner Z; Acton JD; Ge B; Hewett J
    Clin Respir J; 2018 Aug; 12(8):2397-2403. PubMed ID: 29920961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spirometric profile of narghile smokers.
    Ben Saad H; Khemis M; Bougmiza I; Prefaut C; Aouina H; Mrizek N; Garrouche A; Zbidi A; Tabka Z
    Rev Mal Respir; 2011 Sep; 28(7):e39-51. PubMed ID: 21943546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Utility of normality low limit of spirometry in diagnosed COPD patients].
    Naveiro-Rilo JC; García García S; Flores-Zurutuza L; Carazo Fernández L; Domínguez Fernández C; Palomo García JL
    Rev Calid Asist; 2017; 32(5):262-268. PubMed ID: 28863965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.
    Bhatt SP; Sieren JC; Dransfield MT; Washko GR; Newell JD; Stinson DS; Zamba GK; Hoffman EA;
    Thorax; 2014 May; 69(5):409-14. PubMed ID: 23525095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
    Mohamed Hoesein FA; Zanen P; Lammers JW
    Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating FVC from FEV2 and FEV3: assessment of a surrogate spirometric parameter.
    Ioachimescu OC; Venkateshiah SB; Kavuru MS; McCarthy K; Stoller JK
    Chest; 2005 Sep; 128(3):1274-81. PubMed ID: 16162718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes.
    Cerveri I; Corsico AG; Accordini S; Niniano R; Ansaldo E; Antó JM; Künzli N; Janson C; Sunyer J; Jarvis D; Svanes C; Gislason T; Heinrich J; Schouten JP; Wjst M; Burney P; de Marco R
    Thorax; 2008 Dec; 63(12):1040-5. PubMed ID: 18492741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.
    Zaigham S; Wollmer P; Engström G
    Eur Respir J; 2016 Mar; 47(3):742-50. PubMed ID: 26647443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of diagnostic criteria on the prevalence of COPD.
    Çolak Y; Løkke A; Marott JL; Lange P; Vestbo J
    Clin Respir J; 2013 Jul; 7(3):297-303. PubMed ID: 23072716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spirometric reference values for advanced age from a South german population.
    Karrasch S; Flexeder C; Behr J; Holle R; Huber RM; Jörres RA; Nowak D; Peters A; Wichmann HE; Heinrich J; Schulz H;
    Respiration; 2013; 85(3):210-9. PubMed ID: 22797415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons.
    Marcus BS; McAvay G; Gill TM; Vaz Fragoso CA
    J Am Geriatr Soc; 2015 Feb; 63(2):251-7. PubMed ID: 25643966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How Common Is Airflow Limitation in Patients With Emphysema on CT Scan of the Chest?
    Lutchmedial SM; Creed WG; Moore AJ; Walsh RR; Gentchos GE; Kaminsky DA
    Chest; 2015 Jul; 148(1):176-184. PubMed ID: 25539080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers.
    Akkermans RP; Biermans M; Robberts B; ter Riet G; Jacobs A; van Weel C; Wensing M; Schermer T
    Eur Respir J; 2014 Jan; 43(1):54-63. PubMed ID: 23563262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Effect of Pulmonary Function Testing on the Success of Smoking Cessation.
    Salepci B; Caglayan B; Fidan A; Parmaksiz ET; Kiral N; Comert SS; Dogan C; Coskun E
    Respir Care; 2016 Aug; 61(8):1073-80. PubMed ID: 26932380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.